News
Announcement
Patient Story
Living Proof: Cancer Vaccine Recipients Bring Their Stories to Capitol Hill
June 4, 2026
584 results
News Coverage
CRISPR-edited T-cells Safely, Effectively Target Cancer Cells in Myeloma Patients, Early Phase 1 Data Suggests
(opens in a new tab)November 13, 2019
News Coverage
ASH: UPenn’s CRISPR-edited immune cells prove safe in small cancer study
(opens in a new tab)November 7, 2019
News Coverage
CRISPR Approach To Fighting Cancer Called 'Promising' In 1st Safety Test
(opens in a new tab)November 6, 2019
News Coverage
Early Results from First-In-U.S. Trial of CRISPR-Edited Immune Cells for Cancer Patients Suggest Safety of Approach
(opens in a new tab)November 6, 2019
News Coverage
Doctors use CRISPR to fight cancer for first time in US
(opens in a new tab)November 6, 2019
News Coverage
Doctors use CRISPR gene editing in cancer patients, a first in the U.S.
(opens in a new tab)November 6, 2019
News Coverage
First use of CRISPR against cancer in patients clears early safety hurdles
(opens in a new tab)November 6, 2019
News Coverage
Doctors try CRISPR gene editing for cancer, a 1st in the US
(opens in a new tab)November 6, 2019
News Coverage
Crispr Takes Its First Steps in Editing Genes to Fight Cancer
(opens in a new tab)November 6, 2019